Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Exercise Test × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12 Breast 12 Thoracic 8 Other hematologic neoplasm 8 Lymphoid 6 Genitourinary 5 Other solid neoplasm 4 Gynecologic 4 Other 3 Plasma cell 2 Other neoplasm 1 Myeloid 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1 Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 290 Nivolumab 259 Ipilimumab 232 Cyclophosphamide 170 aldesleukin 130 Interleukin-2 93 fludarabine phosphate 89 trametinib 78 fludarabine 73 dabrafenib 68 Radiotherapy 67 Dacarbazine 66 Temozolomide 65 Biopsy 63 Vemurafenib 61 Imiquimod 48 Radiosurgery 47 Bevacizumab 46 Magnetic Resonance Spectroscopy 44 sargramostim 43 Blood Specimen Collection 42 3-ingenyl angelate 42 Specimen Handling 41 Aminolevulinic Acid 41 Peripheral Blood Stem Cell Transplantation 40 Paclitaxel 39 Cisplatin 39 cemiplimab 38 Carboplatin 37 atezolizumab 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡